These findings provide novel insights into the effects of NF-κB in pneumonia-induced lung injury, and raise concerns regarding therapeutic potential of inhibiting NF-κB, particularly in prolonged untreated pneumonia. The gene discussed is NFKB1; the disease is susceptibility to pneumonia measurement.